Orifarm A/S and Others (C-400/09) and Paranova Danmark A/S and Paranova Pack A/S (C-207/10) v Merck Sharp & Dohme Corp. and Merck Sharp & Dohme BV and Merck Sharp & Dohme.
Linked as:
Extract
Orifarm A/S and Others (C-400/09) and Paranova Danmark A/S and Paranova Pack A/S (C-207/10) v Merck Sharp & Dohme Corp. and Merck Sharp & Dohme BV and Merck Sharp & Dohme.
No longer available (Autolink)
See the full content of this document
Core Citations
WORK EXPRESSION OF in
- 62010CJ0207
- [2011] ETMR 59
- Orifarm A/S and Others (C-400/09) and Paranova Danmark A/S and Paranova Pack A/S (C-207/10) v Merck Sharp & Dohme Corp. and Merck Sharp & Dohme BV and Merck Sharp & Dohme.
REPORTED OPINION OF in
This document cites
- The Wellcome Foundation Ltd v Paranova Pharmazeutika Handels GmbH.
- Bristol-Myers Squibb contra Paranova A/S (C-427/93) y C. H. Boehringer Sohn, Boehringer Ingelheim KG y Boehringer Ingelheim A/S contra Paranova A/S (C-429/93) y Bayer Aktiengesellschaft y Bayer Danmark A/S contra Paranova A/S (C-436/93).
- MPA Pharma GmbH contra Rhône-Poulenc Pharma GmbH.
- Boehringer Ingelheim KG and Others v Swingward Ltd and Dowelhurst Ltd.
- Directive 2008/95/EC of the European Parliament and of the Council of 22 October 2008 to approximate the laws of the Member States relating to trade marks (Codified version) (Text with EEA relevance)
